Answer
Zidovudine (Retrovir) is used in HIV-positive pregnant women over 14 weeks of gestation to prevent maternal–foetal HIV transmission and for primary prevention of HIV infection in newborns; intravenous Retrovir is reserved for when oral treatment is impossible, except during labour and delivery.
Sources for this answer
- Retrovir10 mg/ml IV for InfusionViiV Healthcare UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 34Document updated
Sources checked